Page last updated: 2024-08-26

cyanopindolol and Adenocarcinoma

cyanopindolol has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lange, F; Lange, J; Morin, D; Tillement, JP; Zini, R	1

Other Studies

1 other study(ies) available for cyanopindolol and Adenocarcinoma

Article	Year
Alterations of beta-adrenergic, muscarinic cholinergic receptors and imipramine binding sites in human lung tumors. International journal of clinical pharmacology, therapy, and toxicology, 1987, Volume: 25, Issue:11 Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Carcinoma, Squamous Cell; Humans; Imipramine; In Vitro Techniques; Lung Neoplasms; Pindolol; Quinuclidinyl Benzilate; Receptors, Adrenergic, beta; Receptors, Cholinergic; Receptors, Muscarinic	1987

Article

Year

Alterations of beta-adrenergic, muscarinic cholinergic receptors and imipramine binding sites in human lung tumors.

International journal of clinical pharmacology, therapy, and toxicology, 1987, Volume: 25, Issue:11

Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Carcinoma, Squamous Cell; Humans; Imipramine; In Vitro Techniques; Lung Neoplasms; Pindolol; Quinuclidinyl Benzilate; Receptors, Adrenergic, beta; Receptors, Cholinergic; Receptors, Muscarinic

1987